References
- Imbach P, Berchtold W, Hirt A. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet. 1985; 2: 464–468
- Blanchette V S, Luke B, Andrew M. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr. 1993; 123: 989–995
- Lusher J M, Emami A, Ravindranath Y, Warrier I A. Idiopathic thrombocytopenic purpura in children (the case for management without corticosteroids). Am J Pediatr Hematol Oncol. 1984; 6: 149–157
- Buchanan G R. The nontreatment of childhood idiopathic thrombocytopenic purpura. Eur J Pediatr. 1987; 146: 107–112
- Woerner S J, Abildgaard C F, French B N. Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura. Pediatrics 1981; 67: 453–460
- Schattner E, Bussel J. Mortality in immune thrombocytopenic purpura: Report of seven cases and consideration of prognostic indicators. Am J Hematol. 1994; 46: 120–126
- Künzlen E, Bauer J, Bertram T, Lampert F, Röttger P, Mueller-Eckhardt C. Fatal outcome of acute thrombocytopenic purpura associated with viral infection in an 11-year-old child. Blut. 1984; 48: 363–367
- Blanchette V, Imbach P, Andrew M. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet. 1994; 344: 703–707